[342 Pages Report] The ureteral stent market is anticipated to rise to US$ 385.9 Million in 2022 and likely to reach US$ 616.8 Million by 2032 with a CAGR of 4.4% from 2022 to 2032.
Demand for ureteral stents is rising as they are made up of fine plastic tubes which are thin and flexibly used to restore urine flow through blocked ureters due to various disorders which are increasing the ureteral stent market growth during the forecast period from 2022 to 2032.
| Report Attribute | Details |
|---|---|
| Ureteral Stent Market Value (2022) | US$ 385.9 Million |
| Ureteral Stent Market Anticipated Forecast Value (2032) | US$ 616.8 Million |
| Ureteral Stent Market Projected Growth Rate (2022 to 2032) | 4.4% |
The adoption of ureteral stent is rising as they are placed in ureters through a surgical procedure commonly known as ureteral stenting. One end of the device is placed in the urinary bladder while the other end remains in the kidney.
The ends may be coiled to prevent dislocation of the device. The stent is most often left temporarily till the blockage is removed. Therefore, it is likely to rise the ureteral stent market share in recent years.
Innovative interface platforms available in the market for stent case management and patient safety have been useful for both physicians and patients are rising the ureteral stent market demand analysis during the forecast period from 2022 to 2032.
Epidemiological data reveals that the prevalence of the stone disease is increasing which indicates that demand for ureteral stent would increase in future. The end-user industries such as Hospitals and Gastrointestinal surgery clinics are the leading industry which is growing the ureteral stent market trends in the market.
These industries are upsurging the demand for the devices which directly increase the sales of ureteral stent during the forecast period.
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The key contributor to the ureteral stent market size includes an increasing number of urological procedures owing to a sedentary lifestyle and expanding elder population base during the forecast period from 2022 to 2032.
Poor dietary habits and fluid intake, increasing obesity levels and a rising caseload of metabolic disorders may fuel the rate of ureteral stent market growth. Advancements in stent composition materials leading to minimizing patient discomfort, mesh stent design and construction can give additional favour in the ureteral stent statistics.
The availability of innovative smartphone applications has grown the ureteral stent market trends for stent case management and patient safety, which are useful for both physicians and patients.
The complex procedure of stent placement, lack of skilled surgeons, complications after removal of the stent and discomfort in living with a ureteral stent with side effects such as increased frequency of passing urine and urgency to pass urine are the major factors that may restraint for ureteral stent market growth.
North America is expected to dominate the ureteral stent market size due to the increased number of urological surgeries, the presence of key global players in the region and continuous centre of attention towards research and development projects.
North America acquired 33.0% of the share in the ureteral stent market share as per the ureteral stent market survey during the forecast period from 2022 to 2032.
Principal Consultant
Europe is projected to register the second position in the ureteral stent market growth owing to favourable patient demographics and developing healthcare infrastructure in the region. The Europe region acquires 29.0% of the share in the ureteral stent market share during the forecast period from 2022 to 2032.
The lack of urologists and insufficient proper training is expected to boost the ureteral stents market demand analysis in the Europe region.
In order to enhance market penetration, startups in the ureteral stent market are also attempting to produce technologically innovative items. This is expected to increase revenue for the organization in the coming years.
The startups in ureteral stent market are adopting several technologies to improve the devices in certain ways are drug-eluting stents, localized stenting and drug-coated stent to boost the future sales of ureteral stent in the coming forecast period.
Adopting a better way in the ureteral stent device is to focus on the comfortable of the device without any infection which is likely to influence the ureteral stent market trends & forecast in coming years.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The key players in the global ureteral stent market include Boston Scientific, Bard Medical, Cook Medical, Coloplast, B.Barun, Applied Medical, Allium Medical, Teleflex, Urotech, Urovision, Opti-Med, Goharshafa, Surgimedik, Mednova, Taewoong Medical and Prosurg, and others.
The key players are the prominent players which are anticipated to influence the ureteral stent market future trends during the forecast period from 2022 to 2032. They are pointing toward the new advanced methodology to boost the adoption of ureteral stent in the coming forecast period from 2022 to 2032.
Recent Developments in Ureteral Stent Market are:
| Report Attribute | Details |
|---|---|
| Growth Rate | CAGR of 4.4% from 2022 to 2032 |
| Base Year for Estimation | 2021 |
| Historical Data | 2016 to 2021 |
| Forecast Period | 2022 to 2032 |
| Quantitative Units | Revenue in USD Million and CAGR from 2022 to 2032 |
| Report Coverage | Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
| Segments Covered |
|
| Regions Covered |
|
| Key Countries Profiled |
|
| Key Companies Profiled |
|
| Customization | Available Upon Request |
The ureteral stent market is likely to advance at a CAGR of 4.4% through 2032.
The North American region holds a ureteral stent market share of 33.0% by 2032.
The ureteral stent market is anticipated to expect US$ 385.9 Million in 2022.
The ureteral stent market is expected to account for US$ 616.8 Million by 2032.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2017-2021 and Forecast, 2022-2032 4.1. Historical Market Size Value (US$ Mn) Analysis, 2017-2021 4.2. Current and Future Market Size Value (US$ Mn) Projections, 2022-2032 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Mn) Analysis By Type, 2017-2021 5.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Type, 2022-2032 5.3.1. Open End Stents 5.3.2. Closed End Stents 5.3.3. Double Pigtail Stents 5.3.4. Multiloop Stents 5.4. Y-o-Y Growth Trend Analysis By Type, 2017-2021 5.5. Absolute $ Opportunity Analysis By Type, 2022-2032 6. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Composition Material 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Mn) Analysis By Composition Material, 2017-2021 6.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Composition Material, 2022-2032 6.3.1. Polyurethane Stents 6.3.2. Silicone Stents 6.3.3. Hydrogel Stents 6.3.4. Plastic Stents 6.3.5. Metal Stents 6.3.6. Coated Stents 6.4. Y-o-Y Growth Trend Analysis By Composition Material, 2017-2021 6.5. Absolute $ Opportunity Analysis By Composition Material, 2022-2032 7. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Mn) Analysis By Application, 2017-2021 7.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By Application, 2022-2032 7.3.1. Lithotripsy 7.3.2. Ureterorenoscopy 7.3.3. Schistosomiasis 7.4. Y-o-Y Growth Trend Analysis By Application, 2017-2021 7.5. Absolute $ Opportunity Analysis By Application, 2022-2032 8. Global Market Analysis 2017-2021 and Forecast 2022-2032, By End User 8.1. Introduction / Key Findings 8.2. Historical Market Size Value (US$ Mn) Analysis By End User, 2017-2021 8.3. Current and Future Market Size Value (US$ Mn) Analysis and Forecast By End User, 2022-2032 8.3.1. Hospitals 8.3.2. Gastrointestinal Surgery Clinics 8.4. Y-o-Y Growth Trend Analysis By End User, 2017-2021 8.5. Absolute $ Opportunity Analysis By End User, 2022-2032 9. Global Market Analysis 2017-2021 and Forecast 2022-2032, By Region 9.1. Introduction 9.2. Historical Market Size Value (US$ Mn) Analysis By Region, 2017-2021 9.3. Current Market Size Value (US$ Mn) Analysis and Forecast By Region, 2022-2032 9.3.1. North America 9.3.2. Latin America 9.3.3. Europe 9.3.4. Asia Pacific 9.3.5. MEA 9.4. Market Attractiveness Analysis By Region 10. North America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 10.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 10.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 10.2.1. By Country 10.2.1.1. US 10.2.1.2. Canada 10.2.2. By Type 10.2.3. By Composition Material 10.2.4. By Application 10.2.5. By End User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By Composition Material 10.3.4. By Application 10.3.5. By End User 10.4. Key Takeaways 11. Latin America Market Analysis 2017-2021 and Forecast 2022-2032, By Country 11.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 11.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 11.2.1. By Country 11.2.1.1. Brazil 11.2.1.2. Mexico 11.2.1.3. Rest of Latin America 11.2.2. By Type 11.2.3. By Composition Material 11.2.4. By Application 11.2.5. By End User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By Composition Material 11.3.4. By Application 11.3.5. By End User 11.4. Key Takeaways 12. Europe Market Analysis 2017-2021 and Forecast 2022-2032, By Country 12.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 12.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 12.2.1. By Country 12.2.1.1. Germany 12.2.1.2. U.K. 12.2.1.3. France 12.2.1.4. Spain 12.2.1.5. Italy 12.2.1.6. Rest of Europe 12.2.2. By Type 12.2.3. By Composition Material 12.2.4. By Application 12.2.5. By End User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By Composition Material 12.3.4. By Application 12.3.5. By End User 12.4. Key Takeaways 13. Asia Pacific Market Analysis 2017-2021 and Forecast 2022-2032, By Country 13.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 13.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.1.4. Rest of Asia Pacific 13.2.2. By Type 13.2.3. By Composition Material 13.2.4. By Application 13.2.5. By End User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By Composition Material 13.3.4. By Application 13.3.5. By End User 13.4. Key Takeaways 14. MEA Market Analysis 2017-2021 and Forecast 2022-2032, By Country 14.1. Historical Market Size Value (US$ Mn) Trend Analysis By Market Taxonomy, 2017-2021 14.2. Market Size Value (US$ Mn) Forecast By Market Taxonomy, 2022-2032 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Type 14.2.3. By Composition Material 14.2.4. By Application 14.2.5. By End User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By Composition Material 14.3.4. By Application 14.3.5. By End User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. US 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2021 15.1.2.1. By Type 15.1.2.2. By Composition Material 15.1.2.3. By Application 15.1.2.4. By End User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2021 15.2.2.1. By Type 15.2.2.2. By Composition Material 15.2.2.3. By Application 15.2.2.4. By End User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2021 15.3.2.1. By Type 15.3.2.2. By Composition Material 15.3.2.3. By Application 15.3.2.4. By End User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2021 15.4.2.1. By Type 15.4.2.2. By Composition Material 15.4.2.3. By Application 15.4.2.4. By End User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2021 15.5.2.1. By Type 15.5.2.2. By Composition Material 15.5.2.3. By Application 15.5.2.4. By End User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2021 15.6.2.1. By Type 15.6.2.2. By Composition Material 15.6.2.3. By Application 15.6.2.4. By End User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2021 15.7.2.1. By Type 15.7.2.2. By Composition Material 15.7.2.3. By Application 15.7.2.4. By End User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2021 15.8.2.1. By Type 15.8.2.2. By Composition Material 15.8.2.3. By Application 15.8.2.4. By End User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2021 15.9.2.1. By Type 15.9.2.2. By Composition Material 15.9.2.3. By Application 15.9.2.4. By End User 15.10. China 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2021 15.10.2.1. By Type 15.10.2.2. By Composition Material 15.10.2.3. By Application 15.10.2.4. By End User 15.11. Japan 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2021 15.11.2.1. By Type 15.11.2.2. By Composition Material 15.11.2.3. By Application 15.11.2.4. By End User 15.12. South Korea 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2021 15.12.2.1. By Type 15.12.2.2. By Composition Material 15.12.2.3. By Application 15.12.2.4. By End User 15.13. GCC Countries 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2021 15.13.2.1. By Type 15.13.2.2. By Composition Material 15.13.2.3. By Application 15.13.2.4. By End User 15.14. South Africa 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2021 15.14.2.1. By Type 15.14.2.2. By Composition Material 15.14.2.3. By Application 15.14.2.4. By End User 15.15. Israel 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2021 15.15.2.1. By Type 15.15.2.2. By Composition Material 15.15.2.3. By Application 15.15.2.4. By End User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By Composition Material 16.3.4. By Application 16.3.5. By End User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Boston Scientific 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.2. Bard Medical 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.3. Cook Medical 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.4. Coloplast 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.5. B.Barun 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.6. Applied Medical 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.7. Allium Medical 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.8. Teleflex 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.9. Opti-Med 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.10. Goharshafa 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.11. Surgimedik 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.12. Mednova 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.13. Taewoong Medical 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.14. Prosurg 17.1.14.1. Overview 17.1.14.2. Product Portfolio 17.1.14.3. Profitability by Market Segments 17.1.14.4. Sales Footprint 17.1.14.5. Strategy Overview 17.1.14.5.1. Marketing Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Ureteral Stent Market
